An escalating trade war killed any hope for a rebound.
Big Blue is part of the team that will help develop a blockchain network to trace prescription drugs.
It tells investors little about how much genuine recurring revenue the online pet products retailer really generates.
The company is now much more optimistic about its second quarter.
The middle of NVIDIA's product stack is under attack.
The chip company may not be able to maintain its full-year guidance any longer.
Competition and grade-school arithmetic will eventually put an end to the madness, as it always does.
The U.S. Huawei ban and the U.S.-China trade war will make the memory chip downturn even worse.
Heavy spending on sales and marketing is not producing much growth.
A very strong quarter lit a fire under the stock.
The CEO is out as the company cuts its full-year guidance.
Most of the gains were gone by the end of the day, but investors were clearly excited about the company's solid revenue growth.
It’s taking longer for the company to close deals.
The dividend is dead as sales and profits tumble.
The video game retailer’s sky-high yield is no more.
Don't miss out on these small-cap bargains.
The first two generations helped AMD make a comeback. The next one could seriously threaten Intel’s dominance in PC CPUs.
The company is going after a multibillion-dollar market.
The company's results are largely holding up in a tough data center market.
It took just three months for the chip company to abandon its overly optimistic outlook.